Molecular Basis of Cancer: Therapeutics and Targets
Unraveling cancer’s secrets: Design smarter therapies for a brighter future.
Online/ e-LMS
Live Industrial Course
Advanced
3 Months
Batches
Live
Program Aim
To equip participants with a comprehensive understanding of the molecular mechanisms underlying cancer and explore the development of targeted therapies based on these insights.
About Program
This program delves into the intricate world of the molecular basis of cancer. Through a combination of lectures, discussions, and case studies, participants will gain a deeper understanding of the cellular and molecular underpinnings of cancer, and how these insights are translated into targeted therapeutic approaches.
Program Objectives
- Explore the hallmarks of cancer and their molecular basis.
- Analyze different types of mutations and their role in cancer initiation and progression.
- Understand the principles of targeted cancer therapy.
- Discuss the latest advancements in targeted therapies (e.g., small molecules, antibodies, immunotherapies).
- Analyze the challenges associated with drug resistance and treatment optimization.
- Explore emerging therapeutic strategies for personalized cancer medicine.
Program Structure
Introduction to Cancer Biology
- Overview of cancer: Definitions, types, and fundamental concepts
- The cellular and genetic basis of cancer
Key Molecular Pathways in Cancer
- Signal transduction pathways
- Cell cycle regulation and apoptosis
Technologies in Cancer Research
- Molecular diagnostics and biomarkers
- Imaging and other diagnostic tools
Cancer Genomics
- Understanding genetic mutations and their roles in cancer
- High-throughput sequencing techniques
Targeted Cancer Therapy
- Principles of targeted therapy
- Case studies of successful targeted therapies (e.g., HER2 inhibitors, TKIs)
Emerging Therapeutics in Oncology
- Immunotherapies (CAR-T cells, checkpoint inhibitors)
- Gene therapy and oncolytic viruses
Drug Development and Clinical Trials
- The drug development process: From bench to bedside
- Designing and conducting oncology clinical trials
Ethical and Regulatory Considerations
- Ethical issues in cancer treatment and research
- Regulatory landscape for drug approval
Participant’s Eligibility
- Biotech, Pharma, and Life Sciences graduates
- Post-graduates with a focus on oncology, cell biology, or molecular biology
- Academicians researching cancer biology or therapeutics
- Industry professionals seeking to update their knowledge in cancer research and drug development
- Anyone interested in the molecular basis of cancer and the development of novel therapies.
Program Outcomes
- Acquire a strong foundation in the molecular mechanisms driving cancer development.
- Gain insights into the rationale behind targeted therapies for various cancers.
- Develop an understanding of the challenges and opportunities in cancer therapeutics.
- Identify potential career paths within the field of cancer research and drug discovery.
Fee Structure
Standard Fee: INR 49,998 USD 1,300
Discounted Fee: INR 24999 USD 650
Certificate
Program Deliverables
- Comprehensive course materials
- Interactive case studies
- Guest lectures from leading cancer researchers
- Networking opportunities with industry professionals and academicians
- Certificate of completion
- Certificate of Publication
Future Career Prospects
The field of cancer research and therapeutics is constantly evolving. Graduates of this program will be well-positioned to pursue rewarding careers in various sectors, including:
- Pharmaceutical and biotechnology companies
- Academic research institutions
- Government agencies (e.g., National Cancer Institute)
- Non-profit organizations focused on cancer research and advocacy
- Contract research organizations (CROs)
Job Opportunities
- Cancer researcher
- Medicinal chemist
- Cancer pharmacologist
- Biomarker discovery scientist
- Clinical trial manager
- Bioinformatics analyst
- Regulatory affairs specialist
- Science writer/communicator
